Codes / ICD10CM / T50.B12D

T50.B12D Poisoning by smallpox vaccines, intentional self-harm, subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by smallpox vaccines, intentional self-harm, subsequent encounter

Summary

This condition involves harmful effects resulting from intentional self-administration of smallpox vaccines, with the encounter occurring during the recovery or follow-up phase after the initial event. Clinical management focuses on ongoing monitoring, addressing residual symptoms, and supporting mental health needs.

Causes

Intentional self-harm with smallpox vaccines may occur through deliberate ingestion, injection, or contact with vaccine material. The act is typically driven by suicidal intent or self-injurious behavior, and the subsequent encounter reflects ongoing care following the initial incident.

Risk Factors

  • History of mental health conditions (e.g., depression, suicidal ideation)
  • Access to vaccine materials
  • Prior self-harm behaviors
  • Substance use disorders

Symptoms

  • Localized reactions (e.g., swelling, redness at exposure site)
  • Systemic symptoms (e.g., fever, malaise)
  • Allergic reactions (e.g., rash, itching)
  • Neurological symptoms (e.g., dizziness, confusion)
  • Gastrointestinal disturbances (e.g., nausea, vomiting)

Diagnosis

Diagnosis is based on the patient's history of intentional exposure, clinical examination, and symptom evaluation. Laboratory tests may be used to rule out other conditions or confirm vaccine-related effects. The "subsequent encounter" designation indicates care during the recovery phase.

Treatment Options

  • Symptomatic relief (e.g., antihistamines for mild reactions, pain management)
  • Monitoring for severe reactions (e.g., anaphylaxis, organ involvement)
  • Psychiatric evaluation and support
  • Wound care or management of residual effects

Prognosis and Follow-Up

Prognosis depends on the severity of the initial exposure and response to treatment. Follow-up care focuses on resolving symptoms, preventing recurrence, and addressing underlying mental health concerns. Regular monitoring may be necessary to assess recovery and adjust interventions.

Complications

  • Persistent localized or systemic reactions
  • Psychological distress or suicidal ideation
  • Secondary infections at exposure sites
  • Allergic or hypersensitivity reactions

Lifestyle & Prevention

  • Secure storage of vaccine materials to limit access
  • Mental health support and counseling for at-risk individuals
  • Education on safe handling and disposal of vaccine products
  • Regular screening for suicidal ideation in high-risk populations

When to Seek Professional Help

Seek immediate medical attention if symptoms worsen, new severe reactions occur, or suicidal thoughts emerge. Ongoing psychiatric care is recommended for individuals with a history of self-harm to address underlying issues.

Tips for Medical Coders

Use this code for encounters related to intentional self-harm with smallpox vaccines during the recovery phase. Document the nature of the exposure, current symptoms, and treatment provided. Ensure the encounter is classified as "subsequent" to align with the code's intent, and verify that the event was intentionally self-inflicted.

Book a walkthrough

T50.B12D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.